Mahamaya Lifesciences Board Meeting on Nov 13 to Approve Unaudited Financials

Mahamaya Lifesciences Ltd has announced that its Board of Directors will convene on November 13, 2026. The primary agenda for this meeting is to consider and approve the unaudited financial results for both standalone and consolidated operations for the half-year period ending September 30, 2026. Concurrently, the company has informed that the trading window for its equity shares, which commenced on October 01, 2026, will remain closed until November 16, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations. The company's website will also host this information.